论文部分内容阅读
目的:观察并探究甲氨蝶呤序贯米非司酮保守治疗剖宫产子宫切口妊娠的临床疗效。方法:选取我院收治的62例行剖宫产子宫切口妊娠的患者为研究对象,随机分成对照组与实验组,每组31例。给予对照组甲氨蝶呤单药治疗,实验组则接受甲氨蝶呤序贯米非司酮保守治疗,统计并分析两组患者的治疗效果。结果:实验组的治愈率为93.55%,明显高于对照组(80.65%),两组数据差异显著,具备统计学意义(P<0.05)。结论:在治疗剖宫产子宫切口妊娠中,采用甲氨蝶呤序贯米非司酮的保守治疗方法,具有非常高的治愈率,效果显著,值得临床推广与应用。
Objective: To observe and explore the clinical efficacy of methotrexate sequential mifepristone conservative treatment of cesarean section uterine incision pregnancy. Methods: Totally 62 pregnant women undergoing cesarean section uterine incision pregnancy in our hospital were randomly divided into control group and experimental group, with 31 cases in each group. The control group received methotrexate monotherapy, while the experimental group received conservative treatment of methotrexate followed by mifepristone. The therapeutic effect was statistically analyzed and analyzed in both groups. Results: The cure rate of the experimental group was 93.55%, which was significantly higher than that of the control group (80.65%). There was significant difference between the two groups (P <0.05). Conclusion: In the treatment of cesarean section uterine incision pregnancy, methotrexate sequential mifepristone conservative treatment, has a very high cure rate, the effect is significant, worthy of clinical promotion and application.